Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06887452 · ClinicalTrials.gov registry record · NA
Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With Gout
A NA study, sponsored by VA Office of Research and Development.
- Not yet
- Registry status
- NA
- Development phase
- 310
- Enrollment target
NCT06887452: Clinical Trial NA study, sponsored by VA Office of Research and Development.
NCT06887452 is a NA study that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 310 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06887452, a NA study, has not yet begun recruiting, sponsored by VA Office of Research and Development.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 310 participants
- Enrollment target
Study Summary
This study will compare two different approaches to manage medications that lower uric acid levels. This study will be conducted at five VA medical centers across the United States and will take 4-5 years to complete. Individual participation will last up to two years.
Primary Outcome
The occurrence of two or more flares during year 2.
Interventions
- OTHER Pharmacist-Led
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2026-10-01 |
| Est. Completion | 2031-03-30 |
| Phase | NA |
What is known before NCT06887452 opens enrollment
NCT06887452 is an interventional study that assigns participants to a tested intervention. The registered 310 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 1 intervention - of which Pharmacist-Led is the first listed.
NCT06887452 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06887452 about?
NCT06887452 is a clinical study titled "Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With Gout". This study will compare two different approaches to manage medications that lower uric acid levels. This study will be conducted at five VA medical centers across the United States and will take 4-5 years to complete. Individual participation will last up to two years.
What is the current status of trial NCT06887452?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 310 participants. The study started on 2026-10-01. Estimated completion is 2031-03-30.
What interventions are being tested in trial NCT06887452?
The interventions under investigation include: Pharmacist-Led (OTHER).
Who is sponsoring clinical trial NCT06887452?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06887452's enrollment target sits among peer trials
310 323rd of 2000 higher than 1,678 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03039439 · 310 participants
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
- NCT04178018 · 310 participants · NA
Transvaginal Ultrasound and Photoacoustic Imaging of Ovary
- NCT04878094 · 310 participants · Phase 3
A Study of Intra-operative Imaging in Women With Ovarian Cancer
- NCT05459233 · 310 participants · NA
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI